Institutional Repository UDD

Characterization of diabetic neuropathy progression in a mouse model of type 2 diabetes mellitus

Show simple item record

dc.contributor.author Gregorio, Cristian De
dc.contributor.author Contador, David
dc.contributor.author Campero, Mario
dc.contributor.author Ezquer, Marcelo
dc.contributor.author Ezquer, Fernando
dc.date.accessioned 2019-07-18T21:02:35Z
dc.date.available 2019-07-18T21:02:35Z
dc.date.issued 2018
dc.identifier.citation Biology Open, 2018, n° 7, 11 p.
dc.identifier.uri http://hdl.handle.net/11447/2533
dc.identifier.uri http:dx.doi.org/10.1242/bio.036830
dc.description.abstract Diabetes mellitus (DM) is one of most common chronic diseases with an increasing incidence in most countries. Diabetic neuropathy (DN) is one of the earliest and main complications of diabetic patients, which is characterized by progressive, distal-to-proximal degeneration of peripheral nerves. The cellular and molecular mechanisms that trigger DN are highly complex, heterogeneous and not completely known. Animal models have constituted a valuable tool for understanding diabetes pathophysiology; however, the temporal course of DN progression in animal models of type 2 diabetes (T2DM) is not completely understood. In this work, we characterized the onset and progression of DN in BKS diabetic (db/db) mice, including the main functional and histological features observed in the human disease. We demonstrated that diabetic animals display progressive sensory loss and electrophysiological impairments in the early-to-mid phases of the disease. Furthermore, we detected an early decrease in intraepidermal nerve fiber (IENF) density in 18-week-old diabetic mice, which is highly associated with sensory loss and constitutes a reliable marker of DN. Other common histological parameters of DN – like Schwann cells apoptosis and infiltration of CD3+ cells in the sciatic nerve – were altered in mid-to-late phases of the disease. Our results support the general consensus that DN evolves from initial functional to late structural changes. This work aimed to characterize the progression of DN in a reliable animal model sharing the main human disease features, which is necessary to assess new therapies for this complex disease. Finally, we also aimed to identify an effective temporal window where these potential treatments could be successfully applied.
dc.format.extent 11 p.
dc.language.iso en
dc.subject Diabetic neuropathy
dc.subject Type 2 diabetes mellitus
dc.subject Animal model
dc.subject Peripheral nerves
dc.subject Axonal degeneration
dc.title Characterization of diabetic neuropathy progression in a mouse model of type 2 diabetes mellitus
dc.type Article


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account